Continental Senior Communities Expands Tenera Care Partnership Following Breakthrough Success at Dublin Glenn

Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics

MS Pharma anuncia una inversión estratégica para su crecimiento por parte de Olayan Financing Company

SHARx Calls for Accountability as Policymakers Target PBM Practices Nationwide

FDA Approves IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi), First Biosimilars to Simponi® (golimumab) and Simponi Aria® (golimumab); Accord BioPharma to Lead U.S. Commercialization

THE ACADEMY OF GEROSCIENCE WELCOMES SIXTEEN LEADING SCIENTISTS AS NEW MEMBERS

FDA Grants Breakthrough Therapy Designation to VERTANICAL's VER-01, a First-in-Class Non-Opioid Investigational Treatment for Chronic Low Back Pain

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs

Biotheryx Announces Data from its Phase 1 Dose Escalation Study of BTX-9341, a First-in-Class, Potent and Selective CDK4/6 Degrader, for the Treatment of Advanced/Metastatic HR+/HER2- Breast Cancer

MS Pharma Announces Strategic Growth Investment from Olayan Financing Company

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)

Samson Clinical Announces Last Patient Last Visit in its Pivotal Phase III Study of Sublingual Minoxidil for Male Androgenetic Alopecia

Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial

Triquetra Health Launches Instant Aminos--First Free-Form EAA Tablets Delivering All 9 Essential Amino Acids with Zero Bloating

Bracco and ACIST Medical Systems Announce U.S. FDA Clearance of ACIST Pro™ Diagnostic System

Triquetra Health Launches FolinicActive™ Adult Liquid--First Multi-Pathway Active Folate with Complete Tri-Cofactor System

Triquetra Health Launches FolinicActive™--First Multi-Pathway Active Folate with Complete Tri-Cofactor System

AspenRidge Recovery Expands Into Mental Health Treatment, Relocates to Downtown Colorado Springs

Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease

Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate

WuXi AppTec Recognized as a Top-Performing Company on 2026 Dow Jones Best-in-Class World Index

HelloNation Article Featuring Personal Injury Attorney Joe Stanley Explains What Determines a Personal Injury Case Value

NAMI Elects New 2026-2027 Board Leadership to Advance Mental Health for All

Trella Health Launches Physician Group Explore & Analyze to Help Post-Acute Organizations Identify High-Value Referral Opportunities

The Lustgarten Foundation Honors Pioneers in Pancreatic Cancer Research at Annual Inspiring Hope Gala

Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY® (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11β‑Hydroxylase Deficiency at ENDO 2026

MNA: Healthcare Workers to Display 40 Medical Scrubs on State House Steps During Press Event Highlighting Daily Toll of Workplace Violence

The Inner Circle acknowledges Donna M. Brester, MSN, RN, CCRN, NPDS, for her outstanding contributions for 2026 as a compassionate caregiver and advocate in critical nursing care

The Inner Circle acknowledges Dr. Marcia L. Dinkins as an Inner Circle Five Year